PREVENTION AND TREATMENT OF COMPLEMENT-ASSOCIATED EYE CONDITIONS

摘要

The invention concerns the prevention and treatment of complement-associated eye conditions, such as choroidal neovascularization (CNV) and age-related macular degeneration (AMD), by administration of Factor D antagonists.